These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31628917)

  • 1. Small molecule PIKfyve inhibitors as cancer therapeutics: Translational promises and limitations.
    Ikonomov OC; Sbrissa D; Shisheva A
    Toxicol Appl Pharmacol; 2019 Nov; 383():114771. PubMed ID: 31628917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIKfyve inhibitor cytotoxicity requires AKT suppression and excessive cytoplasmic vacuolation.
    Ikonomov OC; Altankov G; Sbrissa D; Shisheva A
    Toxicol Appl Pharmacol; 2018 Oct; 356():151-158. PubMed ID: 30098992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns(3,5)P2 by means of the PIKfyve inhibitor YM201636.
    Sbrissa D; Ikonomov OC; Filios C; Delvecchio K; Shisheva A
    Am J Physiol Cell Physiol; 2012 Aug; 303(4):C436-46. PubMed ID: 22621786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apilimod, a candidate anticancer therapeutic, arrests not only PtdIns(3,5)P2 but also PtdIns5P synthesis by PIKfyve and induces bafilomycin A1-reversible aberrant endomembrane dilation.
    Sbrissa D; Naisan G; Ikonomov OC; Shisheva A
    PLoS One; 2018; 13(9):e0204532. PubMed ID: 30240452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active vacuolar H+ ATPase and functional cycle of Rab5 are required for the vacuolation defect triggered by PtdIns(3,5)P2 loss under PIKfyve or Vps34 deficiency.
    Compton LM; Ikonomov OC; Sbrissa D; Garg P; Shisheva A
    Am J Physiol Cell Physiol; 2016 Sep; 311(3):C366-77. PubMed ID: 27335171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Three Orthogonal Assays Suitable for the Identification and Qualification of PIKfyve Inhibitors.
    Fogarty K; Kashem M; Bauer A; Bernardino A; Brennan D; Cook B; Farrow N; Molinaro T; Nelson R
    Assay Drug Dev Technol; 2017 Jul; 15(5):210-219. PubMed ID: 28723271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PIKfyve using YM201636 suppresses the growth of liver cancer via the induction of autophagy.
    Hou JZ; Xi ZQ; Niu J; Li W; Wang X; Liang C; Sun H; Fang D; Xie SQ
    Oncol Rep; 2019 Mar; 41(3):1971-1979. PubMed ID: 30569119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class III PI 3-kinase is the main source of PtdIns3P substrate and membrane recruitment signal for PIKfyve constitutive function in podocyte endomembrane homeostasis.
    Ikonomov OC; Sbrissa D; Venkatareddy M; Tisdale E; Garg P; Shisheva A
    Biochim Biophys Acta; 2015 May; 1853(5):1240-50. PubMed ID: 25619930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Lipid Kinase PIKfyve Coordinates the Neutrophil Immune Response through the Activation of the Rac GTPase.
    Dayam RM; Sun CX; Choy CH; Mancuso G; Glogauer M; Botelho RJ
    J Immunol; 2017 Sep; 199(6):2096-2105. PubMed ID: 28779020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PIKfyve by YM-201636 dysregulates autophagy and leads to apoptosis-independent neuronal cell death.
    Martin S; Harper CB; May LM; Coulson EJ; Meunier FA; Osborne SL
    PLoS One; 2013; 8(3):e60152. PubMed ID: 23544129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential roles of PIKfyve and PTEN on phagosomal phosphatidylinositol 3-phosphate dynamics.
    Hazeki K; Nigorikawa K; Takaba Y; Segawa T; Nukuda A; Masuda A; Ishikawa Y; Kubota K; Takasuga S; Hazeki O
    FEBS Lett; 2012 Nov; 586(22):4010-5. PubMed ID: 23068606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding.
    Jefferies HB; Cooke FT; Jat P; Boucheron C; Koizumi T; Hayakawa M; Kaizawa H; Ohishi T; Workman P; Waterfield MD; Parker PJ
    EMBO Rep; 2008 Feb; 9(2):164-70. PubMed ID: 18188180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PIKfyve-ArPIKfyve-Sac3 triad in human breast cancer: Functional link between elevated Sac3 phosphatase and enhanced proliferation of triple negative cell lines.
    Ikonomov OC; Filios C; Sbrissa D; Chen X; Shisheva A
    Biochem Biophys Res Commun; 2013 Oct; 440(2):342-7. PubMed ID: 24070605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIKfyve-Dependent Phosphoinositide Dynamics in Megakaryocyte/Platelet Granule Integrity and Platelet Functions.
    Caux M; Mansour R; Xuereb JM; Chicanne G; Viaud J; Vauclard A; Boal F; Payrastre B; Tronchère H; Severin S
    Arterioscler Thromb Vasc Biol; 2022 Aug; 42(8):987-1004. PubMed ID: 35708031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIKfyve: Partners, significance, debates and paradoxes.
    Shisheva A
    Cell Biol Int; 2008 Jun; 32(6):591-604. PubMed ID: 18304842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIKfyve inhibition interferes with phagosome and endosome maturation in macrophages.
    Kim GH; Dayam RM; Prashar A; Terebiznik M; Botelho RJ
    Traffic; 2014 Oct; 15(10):1143-63. PubMed ID: 25041080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIKfyve, MTMR3 and their product PtdIns5P regulate cancer cell migration and invasion through activation of Rac1.
    Oppelt A; Haugsten EM; Zech T; Danielsen HE; Sveen A; Lobert VH; Skotheim RI; Wesche J
    Biochem J; 2014 Aug; 461(3):383-90. PubMed ID: 24840251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIKfyve accelerates phagosome acidification through activation of TRPML1 while arrests aberrant vacuolation independent of the Ca2+ channel.
    Isobe Y; Nigorikawa K; Tsurumi G; Takemasu S; Takasuga S; Kofuji S; Hazeki K
    J Biochem; 2019 Jan; 165(1):75-84. PubMed ID: 30295876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control.
    Wible DJ; Parikh Z; Cho EJ; Chen MD; Jeter CR; Mukhopadhyay S; Dalby KN; Varadarajan S; Bratton SB
    Cell Death Dis; 2024 Jan; 15(1):80. PubMed ID: 38253602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plentiful PtdIns5P from scanty PtdIns(3,5)P2 or from ample PtdIns? PIKfyve-dependent models: Evidence and speculation (response to: DOI 10.1002/bies.201300012).
    Shisheva A; Sbrissa D; Ikonomov O
    Bioessays; 2015 Mar; 37(3):267-77. PubMed ID: 25404370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.